Respimat®

DEVICE2 trials

Sponsors

Boehringer Ingelheim

Conditions

Healthy

Phase 1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BEA 2180 BR in Healthy Male Volunteers

CompletedNCT02254122

Boehringer IngelheimHealthy

Start: 2004-05-31Updated: 2014-10-01

Safety, Tolerability and Pharmacokinetics of BEA 2180 BR in Healthy Male Volunteers

CompletedNCT02254720

Boehringer IngelheimHealthy

Start: 2006-09-30Updated: 2014-10-02